ATMI Inc

ATMI — Q3 2013 Earnings Presentation

15 slides from ATMI's earnings presentation, Oct 23, 2013

  1. Slide 1: Q3 2013 Earnings Teleconference

    Q3 2013 Earnings Teleconference October 23, 2013 reserved. @ ATMI

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement Statements contained herein that relate to ATMI's future performance, including, without limitation, statements with respect to ATMI's anticipated results of operations or level of business for 2013 or any other future period, are forward-looking statements within the safe harb

  3. Slide 3: Please Join Us: ATMI Investor Day

    ov Q g 2 i= °o 8 2 2 4 oo & & 4 ee i-} a ” o Please Join Us ATMI Investor Day Tuesday, November 19, 2013 9:30 am — 2:30 pm TKP Conference Center 109 W. 39" Street New York, NY For additional information contact: Troy Dewar, CFA Director, Investor Relations and Corporate Communications 203.207.9349 t

  4. Slide 4: Q3 2013 Summary

    Q3 2013 Summary > Microelectronics revenues lower due to: * Uncertain market conditions * Customer inventory management and purchasing delay * Customer material efficiency gains * Isolated pricing pressures * Lower new product sales ov g g 2 i= °o 8 2 oO 2 4 OD & c E & & 4 ee i-} a ” o > LifeScience

  5. Slide 5: Grow the business

    Grow the business * Microelectronics — win advanced nodes at key semiconductor accounts * LifeSciences — leverage intellectual property and technology in biopharmaceutical industry adoption of single-use technology ¢ eVOLV™ — sign additional license agreements in 2013 and 2014; royalty revenues begi

  6. Slide 6: Q3 2013 Financial Results

    $M (except per Q3 ’ Q3 2013 Revenues by share data) us Segment BMi ics 88 Revenue 100.2 jicroelectronics 88% Gross profit 46.3 46% '@ LifeSciences 12% Gross margin Q3 2013 Revenues by Geography Asia 68% North America 20% m Europe 12% Operating income 11.0 11.0% 8.4 $0.26 Operating margin Net income

  7. Slide 7: Microelectronics

    Microelectronics Q3 2013 Microelectronics Revenues by Product Implant 30% Cu Materials 50% i Liquid Packaging 14% m Other 6% Q2 2013 Revenues 87.8 48% 25.3 28.8% Gross margin " 5 Q3 2013 Microelectronics Revenues by Sector m Memory 25% Bi Logic 68% Flat Panel Display 7% Operating income Operating ma

  8. Slide 8: LifeSciences

    LifeSciences Q3 2013 LifeSciences Revenues by Product SUT Consumables 37% SUT Equipment 15% mSUT IP 5% m Sterile Packaging 43% Revenues ngs Teleconference Gross margin Operating income Operating margin (14.1%) > Record revenues on increased demand for single-use technology (SUT) products, especially

  9. Slide 9: Other Financial Data

    ov Q g 2 i= °o 8 2 2 4 oo E & & om ee i-} a ” o Other Financial Data Q3 2013 Q2 2013 Cash and marketable securities Cash from operating activities Capital Expenditures Depreciation & Amortization Headcount > Cash balance grew to $138.3M from $124.6M during the quarter on strong operating cash flow >

  10. Slide 10: Outlook

    ov g g 2 i= °o 8 2 oO 2 4 OD & c E & & 4 ee i-} a ” o Outlook > Microelectronics + Industry forecasts call for 5-10% wafer start growth in 2014 + Incremental margin improvement through volume and mix benefit and ongoing cost reductions + Growth from new products should accelerate as customers ramp >

  11. Slide 11: Thank you for your interest

    @O ATM! Thank you for your interest. For additional information contact: Troy Dewar, CFA Director, Investor Relations and Corporate Communications 203.207.9349 tdewar@atmi.com http://investor.atmi.com ATMI, eVOLV, BrightBlack and the ATMI logo are trademarks or registered trademarks of ©2013ATM,, nc

  12. Slide 12: Appendix

    Appendix

  13. Slide 13: ATMI — a technology company enabling Process Efficiency gains for our customers

    ATMI —a technology company enabling Process Efficiency gains for our customers Revenues ($M) > Diverse Technology Portfolio * >1,000 patents granted since 390 $407 ‘ ie $307 $302 founding * Formulated and synthesized materials 2010 2011 2012 9M 9M * High-integrity material delivery 2012 2013 and pro

  14. Slide 14: Microelectronics — enabling technology for semiconductor manufacturing

    ov g g 2 i= °o 8 2 oO 2 4 oo E & & 4 ee i-} a ” o Microelectronics — enabling technology for semiconductor manufacturing Revenues ($M) $336 $351 $366 $276 $265 2010 «2011 2012 9M 9M 2012 2013 Operating Income ($M)* $109 98 soa $86 577 2010 2011 2012 9M 9M 2012 = 2013 * Excludes $84.6M charge for con

  15. Slide 15: LifeSciences — trusted single-use technology partner

    LifeSciences — trusted single-use technology partner e g g 2 iS S 3 2 Revenues ($M) > Serving critical and cutting-edge life science applications % ga1_ 938 $42 $36 5 | $31 > Enables product development life & get cycle optimization ea) > Creates entirely new market segment < 2010 2011 2012 9M 9M ey

Atmi — Q3 2013 Earnings Presentation on 6ix